TY  - GEN
AU  - Hermiller,James B
AU  - Rutledge,David R
AU  - Gruberg,Luis
AU  - Katopodis,John N
AU  - Lombardi,William
AU  - Mao,Vivian W
AU  - Zhao,Weiying
AU  - Sharma,Samin K
AU  - Tamboli,Hoshedar P
AU  - Wang,Jin
AU  - Jonnavithula,Lalitha
AU  - Sudhir,Krishnankutty
AU  - Krucoff,Mitchell W
TI  - Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study
SN  - 1540-8183
PY  - 2013///1217
KW  - Angioplasty, Balloon, Coronary
KW  - Cardiovascular Agents
KW  - administration & dosage
KW  - Coronary Artery Disease
KW  - therapy
KW  - Drug-Eluting Stents
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - epidemiology
KW  - Prospective Studies
KW  - Sirolimus
KW  - Thrombosis
KW  - United States
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1540-8183.2012.00766.x
ER  -